Chemoinformaics analysis of TETRADEC-2-ENOIC ACID
| Molecular Weight | 226.36 | nRot | 11 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 27 |
| Exact Molecular Weight | 226.193 | nRing | 0 |
| Solubility: LogS | -4.233 | nHRing | 0 |
| Solubility: LogP | 5.738 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 42.3206 |
| nHD | 1 | BPOL | 26.9514 |
| QED | 0.281 |
| Synth | 5.124 |
| Natural Product Likeliness | 2.777 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.051 |
| Pgp-sub | 0.004 |
| HIA | 0.035 |
| CACO-2 | -4.816 |
| MDCK | 0.000021 |
| BBB | 0.071 |
| PPB | 0.979534 |
| VDSS | 1.577 |
| FU | 0.0176267 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.337 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.891 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.106 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.318 |
| CYP3a4-inh | 0.171 |
| CYP3a4-sub | 0.584 |
| CL | 4.455 |
| T12 | 0.017 |
| hERG | 0.01 |
| Ames | 0.069 |
| ROA | 0.09 |
| SkinSen | 0.01 |
| Carcinogencity | 0.045 |
| EI | 0.005 |
| Respiratory | 0.409 |
| NR-Aromatase | 0.024 |
| Antiviral | Yes |
| Prediction | 0.78699 |